Michael Bachmann Selected Research

Michael Bachmann Research Topics

Disease

60	Neoplasms (Cancer) 06/2022 - 09/2004
13	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 09/2004
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2012 - 03/2005
4	Neoplasm Metastasis (Metastasis) 10/2018 - 06/2011
4	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 03/2005
3	Hematologic Neoplasms (Hematological Malignancy) 04/2022 - 01/2020
3	Pheochromocytoma 01/2021 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2005
3	Leukemia 01/2018 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 03/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2013
2	Melanoma (Melanoma, Malignant) 03/2021 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Diabetes Mellitus 01/2021 - 08/2006
2	Disease Progression 09/2020 - 10/2018
2	Tumor Lysis Syndrome 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2016 - 10/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2013 - 03/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022
1	Thrombotic Thrombocytopenic Purpura 01/2021
1	Thromboinflammation 01/2021
1	Infections 01/2021
1	Multiple Myeloma 01/2020
1	Paraganglioma (Paragangliomas) 10/2018
1	Non-Muscle Invasive Bladder Neoplasms 11/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2017
1	Breast Neoplasms (Breast Cancer) 08/2017

Drug/Important Bio-Agent (IBA)

28	AntigensIBA 04/2022 - 01/2007
17	Chimeric Antigen ReceptorsIBA 04/2022 - 01/2010
14	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2004
8	CytokinesIBA 05/2020 - 01/2010
7	Peptides (Polypeptides)IBA 01/2020 - 01/2007
6	AntibodiesIBA 03/2018 - 08/2006
5	Bispecific AntibodiesIBA 09/2014 - 06/2011
5	AutoantibodiesIBA 01/2010 - 03/2005
4	Neoplasm Antigens (Tumor Antigens)IBA 03/2021 - 05/2006
4	EpitopesIBA 01/2020 - 01/2007
4	AutoantigensIBA 11/2012 - 08/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2021 - 01/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 03/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 03/2018
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 10/2018 - 07/2017
2	LuciferasesIBA 10/2018 - 11/2017
2	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2018 - 01/2016
2	CatecholaminesIBA 10/2018 - 01/2016
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2017 - 01/2016
2	Biological ProductsIBA 01/2016 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 08/2006
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2013 - 03/2011
2	AndrogensIBA 06/2011 - 09/2005
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2006 - 09/2004
1	Heavy Chain Fusion Regulatory Protein 1IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	AlbuminsIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	Ghrelin ReceptorsIBA 03/2021
1	GhrelinIBA 03/2021
1	endothelial PAS domain-containing protein 1IBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	FurinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 09/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 06/2020
1	CarbohydratesIBA 05/2020
1	Artificial ReceptorsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Growth Factor ReceptorsIBA 01/2020
1	PSMA-11IBA 01/2019
1	thiocyanateIBA 10/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2018
1	3-methoxytyramine (methoxytyramine)IBA 10/2018
1	Dopamine (Intropin)FDA LinkGeneric 10/2018
1	MetanephrineIBA 10/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2018
1	NormetanephrineIBA 10/2018
1	B7-H1 AntigenIBA 03/2018
1	CTLA-4 AntigenIBA 03/2018
1	ErbB Receptors (EGF Receptor)IBA 11/2017
1	Lysine (L-Lysine)FDA Link 11/2017
1	TrypsinIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Chelating AgentsIBA 07/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 05/2017
1	Diphosphonates (Bisphosphonates)IBA 05/2017
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2017
1	HydrogelsIBA 09/2016

Therapy/Procedure

23	Therapeutics 04/2022 - 06/2007
12	Immunotherapy 06/2022 - 09/2004
5	Precision Medicine 01/2019 - 01/2016
2	Radiotherapy 01/2021 - 01/2020
1	Chemoradiotherapy 03/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2021
1	Investigational Therapies (Experimental Therapy) 03/2021
1	Plasma Exchange 01/2021
1	Radioimmunotherapy 01/2020
1	Cell Transplantation 01/2020
1	Intravenous Injections 10/2018
1	Catheters 11/2017